Santen 32-009

Completed Studies

A Phase IIIB, Multi-National, Multi-Center, Open-Label Extension Study Assessing the long-term Safety of the PRN Intravitreal Injections of DE-109 in subjects with Non-Infectious Uveitis of the Posterior Segment of the Eye who have participated in the SAKURA Development program.

Duration: 12 months

This entry was posted in Uncategorized. Bookmark the permalink.